150 related articles for article (PubMed ID: 19405121)
21. The TLR7 agonist imiquimod selectively inhibits IL-4-induced IgE production by suppressing IgG1/IgE class switching and germline ε transcription through the induction of BCL6 expression in B cells.
Yoon HK; Shim YS; Kim PH; Park SR
Cell Immunol; 2019 Apr; 338():1-8. PubMed ID: 30850088
[TBL] [Abstract][Full Text] [Related]
22. The BCL6 transcriptional program features repression of multiple oncogenes in primary B cells and is deregulated in DLBCL.
Ci W; Polo JM; Cerchietti L; Shaknovich R; Wang L; Yang SN; Ye K; Farinha P; Horsman DE; Gascoyne RD; Elemento O; Melnick A
Blood; 2009 May; 113(22):5536-48. PubMed ID: 19307668
[TBL] [Abstract][Full Text] [Related]
23. Roles of BCL6 in normal and transformed germinal center B cells.
Basso K; Dalla-Favera R
Immunol Rev; 2012 May; 247(1):172-83. PubMed ID: 22500840
[TBL] [Abstract][Full Text] [Related]
24. Sequential transcription factor targeting for diffuse large B-cell lymphomas.
Cerchietti LC; Polo JM; Da Silva GF; Farinha P; Shaknovich R; Gascoyne RD; Dowdy SF; Melnick A
Cancer Res; 2008 May; 68(9):3361-9. PubMed ID: 18451163
[TBL] [Abstract][Full Text] [Related]
25. CRISPR/Cas9 Screens Reveal Multiple Layers of B cell CD40 Regulation.
Jiang C; Trudeau SJ; Cheong TC; Guo R; Teng M; Wang LW; Wang Z; Pighi C; Gautier-Courteille C; Ma Y; Jiang S; Wang C; Zhao B; Paillard L; Doench JG; Chiarle R; Gewurz BE
Cell Rep; 2019 Jul; 28(5):1307-1322.e8. PubMed ID: 31365872
[TBL] [Abstract][Full Text] [Related]
26. A role for Bcl6 in sequential class switch recombination to IgE in B cells stimulated with IL-4 and IL-21.
Kitayama D; Sakamoto A; Arima M; Hatano M; Miyazaki M; Tokuhisa T
Mol Immunol; 2008 Mar; 45(5):1337-45. PubMed ID: 17950876
[TBL] [Abstract][Full Text] [Related]
27. Association of Ig/BCL6 translocations with germinal center B lymphocytes in human lymphoid tissues: implications for malignant transformation.
Yang X; Lee K; Said J; Gong X; Zhang K
Blood; 2006 Sep; 108(6):2006-12. PubMed ID: 16728698
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms of action of BCL6 during germinal center B cell development.
Huang C; Melnick A
Sci China Life Sci; 2015 Dec; 58(12):1226-32. PubMed ID: 26566802
[TBL] [Abstract][Full Text] [Related]
29. Specific peptide interference reveals BCL6 transcriptional and oncogenic mechanisms in B-cell lymphoma cells.
Polo JM; Dell'Oso T; Ranuncolo SM; Cerchietti L; Beck D; Da Silva GF; Prive GG; Licht JD; Melnick A
Nat Med; 2004 Dec; 10(12):1329-35. PubMed ID: 15531890
[TBL] [Abstract][Full Text] [Related]
30. Ambivalent role of BCL6 in cell survival and transformation.
Albagli-Curiel O
Oncogene; 2003 Jan; 22(4):507-16. PubMed ID: 12555064
[TBL] [Abstract][Full Text] [Related]
31. Activation-induced cell death of aggressive histology lymphomas by CD40 stimulation: induction of bax.
Szocinski JL; Khaled AR; Hixon J; Halverson D; Funakoshi S; Fanslow WC; Boyd A; Taub DD; Durum SK; Siegall CB; Longo DL; Murphy WJ
Blood; 2002 Jul; 100(1):217-23. PubMed ID: 12070030
[TBL] [Abstract][Full Text] [Related]
32. BCL6 gene translocation in follicular lymphoma: a harbinger of eventual transformation to diffuse aggressive lymphoma.
Akasaka T; Lossos IS; Levy R
Blood; 2003 Aug; 102(4):1443-8. PubMed ID: 12738680
[TBL] [Abstract][Full Text] [Related]
33. Acetylation inactivates the transcriptional repressor BCL6.
Bereshchenko OR; Gu W; Dalla-Favera R
Nat Genet; 2002 Dec; 32(4):606-13. PubMed ID: 12402037
[TBL] [Abstract][Full Text] [Related]
34. CD40 signaling drives B lymphocytes into an intermediate memory-like state, poised between naïve and plasma cells.
Upadhyay M; Priya GK; Ramesh P; Madhavi MB; Rath S; Bal V; George A; Vaidya T
J Cell Physiol; 2014 Oct; 229(10):1387-96. PubMed ID: 24482285
[TBL] [Abstract][Full Text] [Related]
35. Resveratrol induces apoptosis in transformed follicular lymphoma OCI-LY8 cells: evidence for a novel mechanism involving inhibition of BCL6 signaling.
Faber AC; Chiles TC
Int J Oncol; 2006 Dec; 29(6):1561-6. PubMed ID: 17088997
[TBL] [Abstract][Full Text] [Related]
36. Tumor suppressive BTB/POZ zinc-finger protein ZBTB28 inhibits oncogenic BCL6/ZBTB27 signaling to maintain p53 transcription in multiple carcinogenesis.
Xiang T; Tang J; Li L; Peng W; Du Z; Wang X; Li Q; Xu H; Xiong L; Xu C; Le X; Wei X; Yu F; Li S; Xiao Q; Luo B; Xiang X; Huang A; Lin Y; Ren G; Tao Q
Theranostics; 2019; 9(26):8182-8195. PubMed ID: 31754389
[TBL] [Abstract][Full Text] [Related]
37. The BCL6-associated transcriptional co-repressor, MTA3, is selectively expressed by germinal centre B cells and lymphomas of putative germinal centre derivation.
Jaye DL; Iqbal J; Fujita N; Geigerman CM; Li S; Karanam S; Fu K; Weisenburger DD; Chan WC; Moreno CS; Wade PA
J Pathol; 2007 Sep; 213(1):106-15. PubMed ID: 17573669
[TBL] [Abstract][Full Text] [Related]
38. External signals regulate germinal center fate-determining transcription factors in the A20 lymphoma cell line.
Feng J; Liu X; Ni X; Qi H
Mol Immunol; 2018 Jan; 93():79-86. PubMed ID: 29154209
[TBL] [Abstract][Full Text] [Related]
39. The ITM2B (BRI2) gene is a target of BCL6 repression: Implications for lymphomas and neurodegenerative diseases.
Baron BW; Baron RM; Baron JM
Biochim Biophys Acta; 2015 May; 1852(5):742-8. PubMed ID: 25557390
[TBL] [Abstract][Full Text] [Related]
40. Malignant transformation of Slp65-deficient pre-B cells involves disruption of the Arf-Mdm2-p53 tumor suppressor pathway.
Ta VB; de Bruijn MJ; ter Brugge PJ; van Hamburg JP; Diepstraten HJ; van Loo PF; Kersseboom R; Hendriks RW
Blood; 2010 Feb; 115(7):1385-93. PubMed ID: 20008789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
